Staurosporine-induced G1 arrest in cancer cells depends on an intact pRB but is independent of p16 status

Cancer Letters

Volumn 183, Issue 1, 2002, Pages 103-107

  Zhou, Weibo ^a   Lin, Yuan ^a   Wersto, Robert ^b   Chrest, Joseph ^b   Gabrielson, Edward ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

p16; pRB protein; Staurosporine

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN DERIVATIVE; PROTEIN KINASE; PROTEIN P16; PROTEIN PRB; STAUROSPORINE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RESISTANCE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL TYPE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; DRUG SENSITIVITY; ENZYME INDUCTION; EPITHELIUM CELL; HUMAN; HUMAN CELL; LUNG CANCER; PREDICTION; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN PHOSPHORYLATION;

ADENOCARCINOMA; BREAST NEOPLASMS; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA REPLICATION; ENZYME INHIBITORS; FEMALE; G1 PHASE; HUMANS; KINETICS; LUNG NEOPLASMS; RETINOBLASTOMA PROTEIN; STAUROSPORINE; TUMOR CELLS, CULTURED;

EID: 0037044108     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00101-5     Document Type: Article

References (26)

1. Analogs of staurosporine: Potential anticancer drugs?
2. Inhibition of CDKs as a therapeutic modality
3. Protection of normal proliferating cells against chemotherapy by staurosporine-mediated, selective, and reversible G(1) arrest
4. Enhancement of cisplatin-induced cytotoxicity by 7-hydroxystaurosporine (UCN-01), a new G2-checkpoint inhibitor
5. UCN-01-mediated G1 arrest in normal but not tumor breast cells is pRb-dependent and p53-independent
6. RB status as a determinant of response to UCN-01 in non-small cell lung carcinoma
7. The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1
8. Enhancement of camptothecin-induced cytotoxicity with UCN-01 in breast cancer cells: Abrogation of S/G(2) arrest
9. UCN-01 and camptothecin induce DNA double-strand breaks in p53 mutant tumor cells, but not in normal or p53 negative epithelial cells
10. UCN-01 selectively enhances mitomycin C cytotoxicity in p53 defective cells which is mediated through S and/or G(2) checkpoint abrogation
11. Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells
12. Highly synchronous culture of fibroblasts from G2 block caused by staurosporine, a potent inhibitor of protein kinases
13. Different effects of staurosporine, an inhibitor of protein kinases, on the cell cycle and chromatin structure of normal and leukemic lymphocytes
14. Transformed mammalian cells are deficient in kinase-mediated control of progression through the G1 phase of the cell cycle
15. Reversible G1 arrest of a human lung epithelial cell line by staurosporine
16. G1 arrest and down-regulation of cyclin E/cyclin-dependent kinase 2 by the protein kinase inhibitor staurosporine are dependent on the retinoblastoma protein in the bladder carcinoma cell line 5637
17. Staurosporine-induced G1 arrest is associated with the induction and accumulation of cyclin-dependent kinase inhibitors
18. Role of the p16 tumor suppressor gene in cancer
19. Clonal growth of epithelial cells from normal adult human bronchus
20. Growth of normal human mammary cells in culture
21. Multiple functions of p27(Kip1) and its alterations in tumor cells: A review
22. Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines
23. Structural rearrangement of the retinoblastoma gene in human breast carcinoma
24. Tumor suppressor activity of RB and p53 genes in human breast carcinoma cells
25. A cell cycle regulator potentially involved in genesis of many tumor types
26. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC